Abstract:The purpose of this study was to investigate the its helical integrity. This made penetration of enzymes into in vitro degradation potential of porcine pericardia fixed with biological tissue easier. Of the multifunctional EC test groups, various aldehyde or epoxy compound (EC) fixatives, using tissues fixed with tetrafunctional EC (EX-521) or trifunctional bacterial collagenase and pronase. The fixatives investigated EC (EX-313) had relatively better resistance to degradation were formaldehyde (FA), glutaraldehyde (GA), monofuncthan those fixed with bifunctional EC (EX-810). The extent tional EC (EX-131), and multifunctional ECs (EX-810, EXof degradation for the EX-313 or EX-512 EC fixed tissues was 313, and EX-512). Fresh porcine pericardium was used as a similar to that observed for the FA-or GA-fixed tissues. The control. The test samples were well immersed in a 20-

An ecological risk assessment was undertaken using productivity‐susceptibility analysis (PSA) to determine the relative vulnerability of 52 species caught by fisheries in the waters off eastern Taiwan. Overall, eight and 20 species were classified as having high and moderate vulnerability, respectively, and the remaining 24 species were classified as having low vulnerability. The species with the highest vulnerability scores were caught mainly by longline and gillnet fisheries, highlighting the need for improved data collection to facilitate a more detailed investigation using more quantitative methods. The data quality analysis indicated that the quality of data was classified as “moderate” for economically important species. However, many species were considered data‐limited and thus collecting high‐resolution catch and effort information and conducting biological studies, especially relating to age, growth and reproduction, are recommended to improve the reliability of outputs from data‐limited assessments such as PSA.

No abstract

Anacetrapib is an inhibitor of cholesteryl ester transfer protein (CETP) previously under development as a lipid‐modifying agent that reduces LDL‐cholesterol and increases HDL‐cholesterol in hypercholesterolemic patients. Anacetrapib demonstrates a long terminal half‐life and accumulates in adipose tissue, which contributes to a long residence time of anacetrapib. Given our previous report that anacetrapib distributes into the lipid droplet of adipose tissue, we sought to understand whether anacetrapib affected adipose function, using a diet‐induced obese (DIO) mouse model. Following 20 weeks of treatment with anacetrapib (100 mg/kg/day), levels of the drug increased to approximately 0.6 mmol/L in white adipose tissue. This level of anacetrapib was not associated with any impairment in adipose functionality as evidenced by a lack of any reduction in biomarkers of adipose functionality (plasma adiponectin, leptin, insulin; adipose adiponectin, leptin mRNA). In DIO wild‐type (WT) mice treated with anacetrapib for 2 weeks and then subjected to 30% food restriction during washout to induce weight loss (18%) and fat mass loss (7%), levels of anacetrapib in adipose and plasma were not different between food restricted and ad lib‐fed mice. These data indicate that despite deposition and long‐term residence of ~0.6 mmol/L levels of anacetrapib in adipose tissue, adipose tissue function appears to be unaffected in mice. In addition, these data also indicate that even with severe caloric restriction and acute loss of fat mass, anacetrapib does not appear to be mobilized from the fat depot, thereby solidifying the role of adipose as a long‐term storage site of anacetrapib.